SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026

ConferencePositive

AI Analysis

Summary

SiBionics and PharmaSens presented their automated insulin delivery vision at EASD 2026, focusing on continuous sensing technology for diabetes care. The presentation outlined a multi-chapter exhibition connecting advanced glucose monitoring with future diabetes management.

Importance:3/10

Sentiment:

0.30

diabetesinsulin deliverycontinuous sensingEASD 2026conference

Related Companies

$GLUC $FVNNU

Read the original article

Published by PR Newswire Pharma on October 4, 2026 3:09 AM

Read Original